InsiderClue
Insiders · Profile

Cohlhepp Ryan

President, COO & Interim CEO at Bicara Therapeutics. Filing since 6 Oct 2025. CIK 0002034665

Company
Date
Role
Action
Shares
Amount
Of holding
BCAX Bicara Therapeutics Inc.
8 Sep 2026
President, COO & Interim CEO
Sold on a plan
17,500
$400.72K
8.8%
BCAX Bicara Therapeutics Inc.
10 Aug 2026
President and COO
Sold on a plan
18,750
$524.53K
9.4%
BCAX Bicara Therapeutics Inc.
9 Jul 2026
President and COO
Sold on a plan
536
$15.54K
0.3%
BCAX Bicara Therapeutics Inc.
8 Jul 2026
President and COO
Sold on a plan
28,214
$817.59K
13.4%
BCAX Bicara Therapeutics Inc.
15 May 2026
President and COO
Sold on a plan
12,500
$253.65K
6.1%
BCAX Bicara Therapeutics Inc.
15 Apr 2026
President and COO
Sold on a plan
12,500
$287.59K
6.0%
BCAX Bicara Therapeutics Inc.
16 Mar 2026
President and COO
Sold on a plan
12,500
$245.71K
5.9%
BCAX Bicara Therapeutics Inc.
3 Mar 2026
President and COO
Sold on a plan
17,392
$315.89K
7.8%
BCAX Bicara Therapeutics Inc.
25 Feb 2026
President and COO
Sold on a plan
3,631
$65.50K
1.7%
BCAX Bicara Therapeutics Inc.
22 Jan 2026
President and COO
Sold on a plan
3,828
$69.30K
1.8%
BCAX Bicara Therapeutics Inc.
15 Jan 2026
President and COO
Sold on a plan
149
$2.68K
0.1%
BCAX Bicara Therapeutics Inc.
15 Dec 2025
President and COO
Sold on a plan
12,500
$233.55K
6.2%
BCAX Bicara Therapeutics Inc.
21 Nov 2025
President and COO
Sold on a plan
12,500
$225.59K
6.1%
BCAX Bicara Therapeutics Inc.
15 Oct 2025
President and COO
Sold on a plan
12,500
$226.94K
5.9%
BCAX Bicara Therapeutics Inc.
7 Oct 2025
President and COO
Sold on a plan
10,900
$196.84K
5.1%
BCAX Bicara Therapeutics Inc.
6 Oct 2025
President and COO
Sold on a plan
39,600
$715.00K
16.2%
16 decisions on file.